These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35415922)

  • 1. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
    Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
    Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn"].
    Huang FJ; He Y; Tang J; Zhang M; Chen J; Mu DZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1183-1188. PubMed ID: 36398541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
    Louis D; More K; Oberoi S; Shah PS
    Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin for alloimmune hemolytic disease in neonates.
    Zwiers C; Scheffer-Rath ME; Lopriore E; de Haas M; Liley HG
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD003313. PubMed ID: 29551014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
    Awad HA; Tantawy AA; El-Farrash RA; Ismail EA; Youssif NM
    Blood Transfus; 2014 Apr; 12(2):250-9. PubMed ID: 24333075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.
    Okulu E; Erdeve O; Kilic I; Olukman O; Calkavur S; Buyukkale G; Cetinkaya M; Ulubas D; Demirel N; Hanta D; Ertugrul S; Gultekin ND; Tuncer O; Demir N; Bilgin L; Narli N; Yildiz D; Terek D; Koroglu OA; Seren C; Ozyazici E; Ozdemir R; Turgut H; Narter F; Akin Y; Ozyazici A; Zenciroglu A; Asker HS; Gokmen Z; Salihli M; Bulbul A; Zubarioglu U; Atasay B; Koc E;
    Front Pediatr; 2022; 10():864609. PubMed ID: 35573949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
    Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
    Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
    Keir AK; Dunn M; Callum J
    J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing face of haemolytic disease of the newborn.
    Roberts IA
    Early Hum Dev; 2008 Aug; 84(8):515-23. PubMed ID: 18621490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
    Onesimo R; Rizzo D; Ruggiero A; Valentini P
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.